Yahoo
NasdaqGM - Delayed Quote USD

Braveheart Bio, Inc. (BRVE)

19.46 +0.86 (+4.62%)
At close: November 9 at 4:00:01 PM EST
19.46 +0.03 (+0.15%)
After hours: November 9 at 4:00:47 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2025
Cash Flow from Operating Activities, Indirect
-24,150 -2,014
Cash Flow from Investing Activities
-36,597 -33,569
Cash Flow from Financing Activities
183,576 124,744
Cash and Cash Equivalents, End of Period
122,831 89,161
Cash Flow, Supplemental
Free Cash Flow to Firm
-66,586 -37,201
Capital Expenditure, Calculated
36,569 33,569
Issuance of Capital Stock
184,338 124,744
Repurchase of Capital Stock
0 0
12/31/2025 - 8/6/2026

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: